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Abstract D-Serine was previously identi¢ed in mammalian
brain and was shown to be a co-agonist at the ‘glycine’ site of
the N-methyl-D-aspartate (NMDA)-type receptors. Racemiza-
tion of serine is catalyzed by serine racemase, a pyridoxal 5P-
phosphate-dependent enzyme expressed mainly in brain and liv-
er. NMDA receptor overactivation has been implicated in a
number of pathological conditions and inhibitors of serine race-
mase are thus potentially interesting targets for therapy. We
expressed recombinant mouse serine racemase in insect cells
and puri¢ed it to near homogeneity. The enzyme is a non-co-
valent homodimer in solution and requires divalent cations Mg2+,
Ca2+ or Mn2+ for activity but not for dimerization. In addition
to the racemization it also catalyzes speci¢c elimination of L-Ser
to pyruvate. D-Serine is eliminated much less e⁄ciently. Both
L-serine racemization and elimination activities of serine race-
mase are of comparable magnitude, display alkaline pH opti-
mum and are negligible below pH 6.5.
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1. Introduction
D-Serine has been identi¢ed in rat and mouse brain [1,2],
shown to be co-localized with N-methyl-D-aspartate (NMDA)
receptor immunoreactivity [3,4] and to co-activate at the ‘gly-
cine’ site of the NMDA receptor [3,5^7]. D-Serine has been
localized into the protoplasmic astrocytes which enwrap nerve
terminals in the areas rich in NMDA receptors [3].
The source of D-serine remained elusive until Wolosker et
al. puri¢ed L-Ser racemization activity from rat brain homo-
genates, and cloned the cDNA for mouse serine racemase
(mSR) [8,9]. These authors showed that mSR catalyzes serine
racemization both in vivo [8] and in vitro [9]. Serine racemase
is expressed in liver and brain where it is localized mostly in
the cytoplasm of astrocytes [8]. The human counterpart of
mSR has been cloned recently [10]. Interestingly, putative ho-
mologs of serine racemase occur not only in mammals but
also in yeast Saccharomyces cerevisiae and plant Arabidopsis
thaliana [8]. In mammals, NMDA receptor overactivation has
been implicated in neuronal ischemic injury following cerebral
stroke [11,12] and its hypofunction has been connected with
schizophrenia [13,14].
Very recently, Chumakov et al. identi¢ed a new human
gene that might be associated with schizophrenia [15]. The
gene product was shown to activate D-serine amino oxidase
implicating thus the importance of tight regulation of D-serine
metabolism. Hence, inhibitors or activators of serine racemase
as the biosynthetic enzyme for D-serine are of potential ther-
apeutic interest. In search for potential serine racemase inhib-
itors, Panizzutti et al. identi¢ed an arti¢cial substrate, L-Ser-
O-sulfate, which is not racemized by serine racemase but is
rather eliminated to pyruvate, ammonia and sulfate. This re-
action is much more e⁄cient than serine racemization by the
enzyme [16].
We set out to establish an e⁄cient system for recombinant
expression of mSR for enzymologic analysis and future crys-
tallization and X-ray structure determination of the enzyme.
While investigating the in vitro substrate and reaction speci-
¢city of mSR, we identi¢ed its previously unknown enzymatic
activity, elimination of L-serine to pyruvate. In this paper we
provide enzymatic characterization of the enzyme and analyze
this novel activity in detail.
2. Materials and methods
2.1. Expression and puri¢cation of serine racemase
mSR was obtained from recombinant baculovirus-infected Sf21
cells from ATG Laboratories Inc., Minnesota, USA. Brie£y, serine
racemase gene (GenBank accession number AF148321) was cloned
into pBacPAK9 baculovirus expression vector (Clontech, Palo Alto,
CA, USA) and expressed in Spodoptera frugiperda Sf21 cells. Cells
were harvested by centrifugation and stored at 370‡C for further
use. In order to isolate soluble cytoplasmic fraction, cell pellets were
resuspended in lysis bu¡er (50 mM 2-[4-(2-hydroxyethyl)-1-piperazin-
yl]-ethanesulfonic acid (HEPES) pH 7.2, 10% (v/v) glycerol, 1 mM
MgCl2, 0.1 mM dithiothreitol (DTT), 1 mM phenylmethylsulfonyl
£uoride, 0.05% (w/v) polyethyleneglycol 8000, 50 mM NaCl and 50
WM pyridoxal 5P-phosphate (PLP)) and lysed by three 20 s bursts of
sonication. After centrifugation (15 000Ug, 30 min, 4‡C), the resulting
supernatant was puri¢ed by ion exchange chromatography using Q-
Sepharose Fast Flow (pH 7.2, lysis bu¡er, elution by NaCl gradient)
and gel ¢ltration chromatography using Superdex 200HR (lysis bu¡-
er+150 mM NaCl). For the purpose of molecular mass determination
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of native serine racemase, the gel ¢ltration column was calibrated by
aldolase (158 kDa), bovine serum albumin (67 kDa), ovalbumin (43
kDa) and chymotrypsinogen A (25 kDa). Protein concentration was
quantitated using the Bio-Rad protein assay (Bio-Rad Laboratories
GmbH, Munich, Germany).
2.2. Activity assays
Serine was incubated in the presence of mSR for a de¢ned time, the
reaction was stopped by precipitation of protein by 5% (w/v) tri-
chloroacetic acid which was subsequently removed by extraction
into water-saturated diethyl ether. To quantify substrate racemization,
the extracted reaction mixture was derivatized with 1-£uoro-2,4-dini-
trophenyl-5-L-alanine amide (Marfey’s reagent, [17]) and the resulting
diastereoisomers were resolved on a Zorbax Extend C18 (4.6U250
mm, particle size 5 Wm) reversed phase high-performance liquid chro-
matography (HPLC) column (Agilent Technologies, USA) in an iso-
cratic solvent system composed of 100 mM sodium acetate pH 4.4
and methanol (65:35) and detected by ultraviolet (UV) absorption at
340 nm [18]. Derivatized pure L- and D-Ser were used as calibration
standards.
Formation of pyruvate in Ser racemization reactions was detected
by end-point analysis using lactate dehydrogenase-catalyzed reduction
of pyruvate to lactate by nicotinamide adenine dinucleotide reduced
form (NADH) and subsequent spectrophotometric determination of
NADH at 340 nm. The reaction mixtures were, after protein precip-
itation by 5% (w/v) trichloroacetic acid and diethyl ether extraction,
mixed with the reaction bu¡er to yield 50 mM triethanolamine pH
7.5, 200 WM NADH and 2.5 U lactate dehydrogenase in a ¢nal vol-
ume of 500 Wl and incubated at 37‡C in a thermostated cuvette holder.
The reaction proceeded to completion within 2 min. The calibration
curve was made with 0^130 WM pyruvate and was linear in this con-
centration range.
Kinetic constants for simple Michaelis^Menten kinetics were deter-
mined by non-linear regression using GraFit program, version 5 (Eri-
thacus Software Ltd., Surrey, UK).
3. Results
3.1. Expression and puri¢cation of recombinant serine
racemase
Expression of mSR in baculovirus-infected insect cells re-
sulted in overproduction of active enzyme which was further
puri¢ed by a combination of ion exchange and gel ¢ltration
chromatography (data not shown). The resulting protein
preparation was 90% pure with overall activity yield of 30%
and protein yield of approximately 100 Wg of mSR per 100 mg
of wet Sf21 cell paste (about 2U107 cells). Using densitometry
of sodium dodecyl sulfate^polyacrylamide gel electrophoresis
(SDS^PAGE) gels and puri¢ed enzyme as a mass standard we
estimate that mSR accounts for about 10% of soluble cellular
protein in the producing Sf21 cells.
3.2. Serine racemase catalyzes speci¢c elimination of L-serine
to pyruvate
In the activity tests, Sf21 cells expressing L-galactosidase
were used as a negative control. In our HPLC-based activity
assay, based on derivatization of K-amino groups of the de-
tected amino acids, in the reactions containing serine race-
mase the total amount of L- and D-Ser decreased in time as
opposed to control reactions containing L-galactosidase (data
not shown). We hypothesized that it might be due to a side
reaction catalyzed by serine racemase which causes loss of the
K-amino group. The generalized scheme of possible reaction
mechanisms of PLP-dependent enzyme-catalyzed reactions
with amino acids [19] suggests that serine could alternatively
be reacted directly either to pyruvate or 3P-hydroxypyruvate
(Fig. 1).
We have decided to detect possible formation of pyruvate
by use of its reduction with NADH catalyzed by lactate de-
hydrogenase and spectrophotometric detection of the decrease
in NADH concentration at 340 nm. Lysates of Sf21 cells
expressing mSR or L-galactosidase (negative control) were in-
cubated with 10 mM L- or D-Ser and the content of racemi-
zation products and total serine was determined by derivati-
zation with Marfey’s reagent and HPLC. Whereas zero or
background levels of pyruvate were detected in the negative
Fig. 1. Potentially relevant pyridoxal phosphate-dependent reaction pathways of serine catalyzed by serine racemase.
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control (Sf21 cells expressing L-galactosidase), con¢rming the
absence of any non-speci¢c activity, signi¢cant amounts of
pyruvate were formed in reactions containing serine racemase
(Fig. 2). Strikingly, about ¢ve times more pyruvate is formed
from L-Ser than from D-Ser. Presumably, the pyruvate formed
when D-Ser is the substrate originates from the L-Ser formed
by D-Ser racemization since the observed extent of racemiza-
tion of D-Ser is much lower than that of L-Ser. Mass balance
of the reaction suggests that in addition to the racemization
product and pyruvate, other yet unidenti¢ed reaction prod-
uct(s) is formed.
Taken together, serine is both racemized and eliminated to
pyruvate speci¢cally by serine racemase. L-Ser is converted to
pyruvate more e⁄ciently than D-Ser by serine racemase and
both enantiomers are converted to other unidenti¢ed side
products.
3.3. Serine racemase activity requires presence of divalent
metal ions
Puri¢cation of mSR according to the published original
protocol [9] resulted in a complete loss of racemization activ-
ity. Further analyses revealed that the inactivation was due to
the presence of ethylenediamine tetraacetic acid (EDTA) (data
not shown), an inhibitor of serine racemase [20]. Therefore,
the L-Ser racemization and elimination activities of mSR were
determined in the presence of 1 mM Mg2þ, Ca2þ, Mn2þ, Fe2þ,
Co2þ, Ni2þ, Cu2þ, or Zn2þ (Fig. 3A). Whereas 1 mM Mg2þ
and Mn2þ slightly increase the racemization and elimination
activity, Ca2þ, Fe2þ and Ni2þ were slightly inhibitory and
Cu2þ, Co2þ and Zn2þ inhibited both activities of mSR signi¢-
cantly.
We examined which of the positively tested cations (Mg2þ,
Ca2þ, Mn2þ, Fe2þ and Ni2þ) are able to reactivate the EDTA-
inactivated mSR (Fig. 3B). Highest reactivation was achieved
by 1 mM Mg2þ, which recovered 87% of racemization and
107% of elimination activity. Calcium and manganese were
less e¡ective, recovering 67 and 50% of racemization and 92
and 70% of elimination activity, respectively, and Fe2þ and
Ni2þ could reactivate serine racemase only to less than 25%.
Only Mg2þ, Ca2þ and Mn2þ can thus bind serine racemase
and activate it signi¢cantly. Our ¢ndings are similar to those
of Cook et al. [20], with the di¡erence that we observe highest
activation e¡ect with Mg2þ whereas Cook et al. found Ca2þ
being the most e⁄cient activator. Based on the above results,
we included 1 mM MgCl2 in all bu¡ers throughout all puri-
¢cation steps and kinetic measurements.
3.4. Serine racemase is a non-covalent homodimer
Since most PLP-dependent enzymes are oligomers [19], we
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Fig. 2. Serine racemase catalyzes speci¢c conversion of L-Ser to py-
ruvate and other, uncharacterized product(s). The negative control
(Sf21: :L-gal) shows the absence of a non-speci¢c activity. Lysate
from Sf21 cells expressing serine racemase (Sf21: :mSR) or L-galac-
tosidase (negative control, Sf21: :L-gal) was reacted with 10 mM L-
or D-Ser at pH 8.0, 20 WM PLP and 1 mM MgCl2 at 37‡C for 3 h.
Samples were analyzed for L/D-Ser content by modi¢cation with
Marfey’s reagent and HPLC and for pyruvate content by coupled
reaction with NADH and lactate dehydrogenase as described in Sec-
tion 2. E, L-Ser; F, D-Ser; , pyruvate; , unidenti¢ed product(s).
Fig. 3. A: In£uence of divalent metal cations on mSR activities.
Serine racemase was incubated for 30 min in the presence of 1 mM
individual metal chlorides and subsequently, enzyme activity was de-
termined at pH 8.0, 10 mM L-Ser, 20 WM PLP and 1 mM respective
metal chloride (37‡C, 2 h). B: Reactivation of serine racemase by
divalent metal cations after its inactivation by EDTA. Serine race-
mase was inactivated by 30 min incubation in the presence of 5 mM
EDTA. Thereafter, solutions of individual metal chlorides were
added to 6 mM concentration and enzyme activity was determined
as in A. The amounts of D-Ser were quanti¢ed by HPLC after deri-
vatization with Marfey’s reagent and pyruvate content was deter-
mined by coupled reaction with NADH and lactate dehydrogenase
as described in Section 2. In all cases, each data point represents
the average of three determinations with the maximum relative dif-
ference of 10% between the individual values within the triplicates.
The columns named ‘Ctrl’ refer to mSR activities prior to EDTA
treatment without addition of exogenous divalent metal ions and
the columns named ‘EDTA’ refer to mSR activities after the EDTA
treatment. F, D-Ser; E, pyruvate.
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analyzed the aggregation state of serine racemase by gel per-
meation chromatography (data not shown). Serine racemase
elutes from the Superdex 200HR gel ¢ltration column as a
prominent peak (97% total peak area) of about 78 kDa
(data not shown) which corresponds to a dimer composed
of 37 kDa protomers. This ¢nding is in agreement with the
¢ndings of Cook et al. [20]. The inactivation of mSR by che-
lation of divalent cations by EDTA does not have signi¢cant
in£uence on the dimer stability. The contact between the two
protomers of mSR is mediated by non-covalent bonds since
pure serine racemase migrates as a single band of 37 kDa on
both reducing and non-reducing SDS^PAGE (data not
shown).
3.5. Kinetic parameters of serine racemization and elimination
by serine racemase
We set out to characterize kinetics of the newly discovered
serine elimination activity of serine racemase and compare it
to the kinetics of serine racemization. We measured the de-
pendence of initial reaction velocity on substrate concentra-
tion for L- and D-Ser in pH 8.0, 1 mM MgCl2 and 20 WM
PLP. The corresponding parameters for Michaelis^Menten
kinetics are summarized in Table 1. The Michaelis constant
and the speci¢c activity (Vmax) of racemization of L-Ser
(KM =30 mM and Vmax = 6.6 Wmol mg31 h31) and D-Ser
(KM =49 mM and Vmax = 7.9 Wmol mg31 h31) are consistent
with the published values [9,20]. Speci¢c activity (Vmax) of
7 Wmol mg31 h31 and active enzyme species molecular mass
of 74 kDa (dimer) yields a conversion rate of 1 molecule of
substrate racemized by 1 molecule of enzyme in about 7 s.
Interestingly, serine elimination to pyruvate follows Michae-
lis^Menten kinetics with the KM values about twice higher (L-
Ser) or similar (D-Ser) to those of racemization. The speci¢c
activity (Vmax) of elimination is comparable to the speci¢c
activity (Vmax) of racemization for L-Ser but is about 20-fold
lower for D-Ser, again pointing out the speci¢city of eliminase
activity towards L-Ser.
Both L-serine racemization and elimination activities of ser-
ine racemase are pH dependent and of comparable magni-
tude. The maximum activity window for both activities is
rather broad, from about pH 8.0 to 9.5 (Fig. 4). Both activ-
ities are negligible below pH 6.5 and their alkaline pH op-
timum is typical for PLP-dependent amino acid racemases
[19].
4. Discussion
The closest enzymologically characterized functional ana-
logs of mammalian serine racemases are bacterial and fungal
amino acid racemases. Recombinant alanine racemases from
Mycobacterium tuberculosis and Mycobacterium avium race-
mize alanine with Vmax of about 30 and 60 Wmol mg31 h31,
respectively and KM values of about 1 and 0.5 mM, respec-
tively [21] and alanine racemase from Schizosaccharomyces
pombe racemizes alanine with KM of 5.0 mM and Vmax of
670 Wmol mg31 h31 [22]. The maximal racemization velocities
of L-Ser for native mSR isolated from mouse brain [9] or
recombinant mSR expressed in Escherichia coli [20] are 5
and 6.72 Wmol mg31 h31, respectively. The maximal velocity
of racemization of the natural substrate of mSR is thus about
one to two orders of magnitude lower than the maximal race-
mization velocities of natural substrates of mycobacterial
alanine racemases and a eukaryotic alanine racemase, respec-
tively.
We found that apart from serine racemization, mSR cata-
lyzes speci¢c elimination of L-Ser to pyruvate. Both activities
are comparable in their kinetic parameters. It is intriguing
why a biosynthetic enzyme producing neurotransmitter D-
Ser would also catalyze an apparently useless parallel reaction
producing pyruvate. In the original report of Wolosker et al.
[9], the authors found no evidence for any other than race-
mization activity of serine racemase. However, serine race-
mase has been shown to catalyze elimination of an arti¢cial
substrate, L-Ser-O-sulfate, to pyruvate [16]. Several PLP-de-
pendent enzymes have been shown to catalyze more than one
reaction type with a single substrate, with one reaction being
typically at least two orders of magnitude more e¡ective than
Table 1
Reaction kinetics of racemization and elimination by serine racemase
Reaction Substrate
L-Ser D-Ser
KM (mM) Vmax (Wmol mg31 h31) KM (mM) Vmax (Wmol mg31 h31)
Racemization 30Z 5 6.6Z 0.3 49Z 9 7.9Z 0.4
Elimination to pyruvate 75Z 14 4.6Z 0.4 75Z 27 0.26Z0.04
The reaction bu¡er contained 50 mM HEPES pH 8.0, 20 WM PLP, 1 mM MgCl2 and the respective substrate at varying concentrations. Reac-
tions proceeded for 1 h at 37‡C. Serine content was quanti¢ed by HPLC after derivatization with Marfey’s reagent and pyruvate content was
determined by coupled reaction with NADH and lactate dehydrogenase as described in Section 2.
Fig. 4. The pH dependence of L-Ser racemization and elimination.
Serine racemase was incubated for 2 h at 37‡C with 10 mM L-Ser,
20 WM PLP and 1 mM MgCl2 at the indicated pH. The D-serine
content was quanti¢ed by HPLC after derivatization with Marfey’s
reagent and pyruvate content was determined by coupled reaction
with NADH and lactate dehydrogenase as described in Section 2.
Each data point represents the average of three determinations with
the maximum relative di¡erence of 10% between the individual val-
ues within the triplicates. b, D-Ser; a, pyruvate.
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others [19,23]. Interestingly, the kinetic parameters of L-Ser-O-
sulfate elimination are at the level of the ‘main’, physiologi-
cally relevant activities of E. coli serine hydroxymethyltrans-
ferase and L-threonine aldolase, whereas serine racemization
and elimination activity of serine racemase are at the level of
the described side activities of the two above-mentioned bac-
terial enzymes [23]. Of course, in the elimination reaction,
sulfate is a much better leaving group than water and hence
it is not wholly surprising that L-Ser-O-sulfate is converted to
pyruvate faster than L-Ser. Nevertheless, it must be noted that
there are enzymes in nature that catalyze conversion of L-Ser
to pyruvate and ammonia very e⁄ciently, e.g. the rat liver L-
serine ammonia-lyase (EC number 4.3.1.17). This enzyme has
a speci¢c activity of 16 698 Wmol mg31 h31 [24] which is about
three orders of magnitude higher than that of mSR. These
comparisons might suggest that either the serine racemase
activity in vivo might be upregulated by another cofactor or
covalent modi¢cation of the enzyme-like phosphorylation or,
alternatively, that the true activity and physiological function
of serine racemase are di¡erent from the production of D-Ser.
The fact that serine racemase is expressed also in mouse liver
apart from the brain [8] might suggest the latter possibility,
since the production of D-Ser in liver is irrelevant due to in-
trinsically high levels of D-amino acid oxidase which will ox-
idize D-Ser to pyruvate [25]. Further research in this area is
necessary to elucidate the speci¢city and regulation of activity
of serine racemase in vivo.
After the submission of this manuscript, a paper was pub-
lished by de Miranda et al. [26] that largely con¢rms our data
at the cellular and protein level. In apparent contradiction to
their previous results [9], the authors now also observe the
production of pyruvate upon the enzymatic racemization of
serine both using recombinant serine racemase and in mam-
malian cells transfected by a plasmid coding for serine race-
mase. Moreover, the authors identi¢ed ATP as an activator of
serine racemase.
In summary, mSR was expressed in high yield in a baculo-
virus system and puri¢ed therefrom. We have shown that
mSR is a dimeric enzyme which requires for its activity but
not for its dimerization either Mg2þ, Ca2þ, or Mn2þ. It cata-
lyzes racemization of L-Ser with speci¢c activity of 6.6 Z 0.3
Wmol mg31 h31 and, additionally, conversion of L-Ser to py-
ruvate with speci¢c activity of 4.6 Z 0.4 Wmol mg31 h31, mea-
sured at pH 8.0 and substrate saturation. In contrast, speci¢c
activity of D-Ser conversion to pyruvate is only 0.26Z 0.04
Wmol mg31 h31 whereas the speci¢c activity of D-Ser racemi-
zation is 7.9 Z 0.4 Wmol mg31 h31. Hence, the elimination
activity of mSR is speci¢c for the L-enantiomer of serine.
Both L-Ser racemization and elimination activities display
similar pH dependence with the optimum in the alkaline re-
gion.
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